I. Camacho

Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variables.

J. Ampuero, M. Romero-Gómez, M. Eslam, 2013, Annals of hepatology.

Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy.

M. Romero-Gómez, M. Castro, L. Grande, 2002, Journal of hepatology.

Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy.

M. Romero-Gómez, J. Bautista, Laura Collantes de Terán, 2004, Journal of hepatology.

Oral glutamine challenge is a marker of altered ammonia metabolism and predicts the risk of hepatic encephalopathy

J. Ampuero, M. Romero-Gómez, R. Millán, 2019, Liver international : official journal of the International Association for the Study of the Liver.

Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy

M. Romero-Gómez, L. Grande, I. Camacho, 2004, Hepatology.

Phosphate-activated glutaminase activity is enhanced in brain, intestine and kidneys of rats following portacaval anastomosis.

V. Felipo, J. Bautista, Laura Collantes de Terán, 2006, World journal of gastroenterology.

Metformin Inhibits Glutaminase Activity and Protects against Hepatic Encephalopathy

J. D. del Campo, I. Ranchal, J. Ampuero, 2012, PloS one.